Stocktoria

Rezolute, Inc. RZLT

Nasdaq · stock · Pharmaceutical Preparations · website · IPO 2011-12-23 · LEI

Rezolute, Inc. statistics & valuation

Market cap$485.3M
P / B4.8×
Return on equity-77.1%
Return on capital-81.8%

Market cap as of 2026-06-29. Multiples are price-derived and refreshed daily; everything else from the latest financial reports.

Profitability & efficiency

Gross margin (%)
2017201820192020202120222023202420252026
Operating margin (%)
2017201820192020202120222023202420252026
Return on equity (%)
-237.80% -1737.80% -276.10% -80.10% -27.50% -44.60% -56.60% -45.90% -77.10% 2017201820192020202120222023202420252026
Shares outstanding
49.2M 62166 4.2M 5.9M 8.4M 33.6M 51.2M 53.2M 87.0M 103.9M 2017201820192020202120222023202420252026
Net debt ($)
$1.8M -$37.6M -$77.4M -$27.1M 2017201820192020202120222023202420252026
Share buybacks ($)
2017201820192020202120222023202420252026
Return on assets (%)
-190.80% -1193.00% -248.50% -185.40% -49.10% -26.90% -41.90% -51.60% -42.40% -68.80% 2017201820192020202120222023202420252026
Free cash flow margin (%)
2017201820192020202120222023202420252026
Debt / equity (×)
0.00× 0.00× 0.54× 2017201820192020202120222023202420252026
EPS ($)
-$2.72 -$2.32 -$1.01 -$1.33 -$0.98 -$0.75 2017201820192020202120222023202420252026

Margins and returns computed from annual filings. Falling shares outstanding = buybacks; rising = dilution. Net debt = debt − cash (negative = net cash).

Key ratios (by fiscal year)

RatioFY2026FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017
Return on assets-68.8%-42.4%-51.6%-41.9%-26.9%-49.1%-185.4%-248.5%-1193.0%-190.8%
Return on equity-77.1%-45.9%-56.6%-44.6%-27.5%-80.1%-276.1%-1737.8%753.9%-237.8%
Debt / equity—————0.54×0.00×0.00×-0.86×—
Current ratio9.6814.3713.3920.1861.7821.343.261.450.322.78

Computed from company filings · US · as of 2026-06-30. Facts plus Stocktoria's own computed scores — not investment advice.